Last deal

$8M

Amount

Series C

Stage

23.02.2005

Date

2

all rounds

$12M

Total amount

General

About Company
Scandius BioMedical develops tissue/bone fixation products for the orthopaedic sports medicine market.

Industry

Sector :

Subsector :

founded date

01.01.2000

Number of employees

Last funding type

Series C

IPO status

Private

Description

Scandius BioMedical specializes in developing tissue/bone fixation products for the orthopaedic sports medicine market. Their product lineup includes STRATIS ST, a femoral fixation system that enables surgeons to perform soft tissue anterior cruciate ligament reconstruction arthroscopically. They also offer TriTis, a soft tissue tibial fixation device.
Contacts